TriSalus Life (TLSI) news
Recent news
Trisalus Life Sciences shares rise 10.5% after co says received FDA clearance for its TrinaV advance medical device
Trisalus Life Sciences Inc. (NASDAQ: TSLX) reported a 10.5% increase in its stock price following the announcement that the U.S. Food and Drug Administration (FDA) has granted clearance for its TrinaV advanced medical device [1]. The device, designed for the treatment of chronic wounds, is intended…
AInvest Wire · Sep 23, 2026Trisalus Life Sciences, Inc.: H.C. Wainwright raises target price to $12 from $11
AInvest Wire · Sep 23, 2026Trisalus Life Sciences shares rise 18% premarket after co says received FDA clearance for its TrinaV advance medical device
Trisalus Life Sciences Inc. (NASDAQ: TSLX) reported an 18% increase in premarket trading on September 23, 2026, following the company’s announcement that it received clearance from the U.S. Food and Drug Administration (FDA) for its TrinaV advanced medical device . The device is designed for the…
AInvest Wire · Sep 23, 2026Trisalus Life Sciences Inc: Intends to initiate a limited market release of TrinaV advance device over coming weeks
Trisalus Life Sciences Inc. has announced plans to initiate a limited market release of its TrinaV advance device in the coming weeks, according to recent company communications. This move follows the company’s recent merger with a MedTech firm, which was finalized earlier this year . The TrinaV…
AInvest Wire · Sep 22, 2026Trisalus Life Sciences, Inc.: H.C. Wainwright initiates coverage with buy rating and target price $11
AInvest Wire · Sep 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.